Coherus Oncology
CHRS
CHRS
196 hedge funds and large institutions have $1.51B invested in Coherus Oncology in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 71 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less capital invested
Capital invested by funds: $1.58B → $1.51B (-$69.6M)
2% less funds holding
Funds holding: 201 → 196 (-5)
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
Holders
196
Holding in Top 10
3
Calls
$1.62M
Puts
$1.14M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$18M | |
| 3 | +$14.7M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$9.66M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$6.55M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$17.7M | |
| 3 | -$14.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$12.3M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$8.74M |